Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.13
Delayed Data
As of 3:59pm ET
 -0.33 / -2.88%
Today’s Change
6.36
Today|||52-Week Range
14.15
+5.60%
Year-to-Date

Today’s Trading

Previous close11.46
Today’s open11.52
Day’s range11.13 - 11.52
Volume355,234
Average volume (3 months)640,592
Market cap$1.3B
Dividend yield8.99%
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+491.25%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratio65.5
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.13+2.03%
ACORAcorda Therapeutics ...-4.29-15.73%
SUPNSupernus Pharmaceuti...-0.31-1.18%
PTLAPortola Pharmaceutic...-0.32-1.38%
Data as of 4:00pm ET, 09/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs